Current Capabilities & Services

​This facility helps UC San Diego and external investigators transition cell therapies through IND-enabling and Phase I/II clinical studies. The ACTL features the following capabilities:

• Optimizing manufacturing processes, including scale-up, closed systems, and delivery formats
• Development of Standard Operating Procedures and Batch Production Records
• Cell product manufacturing, including cell enrichment with the CliniMACS System
• Cell product characterization, including standard microbiological release assays, flow cytometry and RT-qPCR assessment
• Secure storage of cell banks and cell products
• Materials risk assessment and selection
• Writing or review of CMC or supporting reports​